Programme Invest In Biomed

You wish

• Direct communication of your project to convince investors
• Obtain personalized feedback on your pitch deck, on substance and form, by experienced professionals in health fundraising
• Be coached on your oral performance
• Present your project to a panel of investors specialized of your domain
• Establish or consolidate links with these investors and obtain their qualitative feedback on your project

The Invest In Biomed program is made for you!

Le programme Invest In Biomed

6 workshops collective or individual March to June 2025, led by experts in health and fundraising

* The face-to-face workshops will be held over a short day, in Montpellier or Marseille

NB : An additional workshop may be offered depending on requests/needs on the consolidation of your fundraising roadmap

You would like to apply

Eligibility criteria:

• Your business is a business innovative in health (product or service innovation)
• Your business is member of Eurobiomed at the time of submission of the application
• Are you looking for between €500k and €5m (pre-seed, seed, series A) financing to reach a key value creation milestone for your project

Selection criteria:

• Your project is based on a technological innovation and demonstrated in a proof of concept
• Your project addresses a well-defined uncovered medical need
• The founding team is solid and equipped with complementary skills
• L’competitive environment is controlled and the target market is attractive
• The company's business model is defined and a business plan is developed
• The development plan is structured, and the financing needs associates are evaluated

In practice

Application deadline: January 31, 2025

Communication of the selection results on February 28, 2025.

The selection of files is based on the review of your file by the Eurobiomed team and a committee of partners from the innovation ecosystem.

Financial conditions of participation

• This program is largely financed by Eurobiomed's public funding partners and by Eurobiomed's own funds, which is committed to supporting you by investing in this program.
• A financial contribution from selected companies is also requested, in the form of an amount invoiced at the start of the program of €2,200 excluding tax.
• An amount of €10,000 excluding tax will also be requested at the closing of a private fundraising event taking place within 18 months following the program (i.e. before December 2026)

A look back at the 2024 edition

The health fundraising experts of the class of 2024

• Sofia ARNAL – AdBio Partners Associate, pharmacist by training
• Sophie BRAUN – Health consultant In Extenso Croissance
• Karine CHORRO – Phost’In Therapeutics, CEO et co-fondatrice, ex deputy director Genepep
• Stéphane DEBONO – Former Deputy CEO and VP of HalioDx
• Vincent FERT – Partner Turenne Groupe, former CEO/President HalioDx
• Pierre HORNUS – CEO/Co-founder Semeia
• Francine LANCELEUR BRENNING – Director Qualitalents, former General Manager/BD MediHandTrace
• Laure Hélène MERCIER – LH Mercier Conseil, consultant in fund raising, IPO, ex CFO Innate Pharma
• Claire NAUSSAC – Operating partner Truffle Capital
• Claire VERSCHELDE – ICOSA, Co-founding Partner, specialized in IP
• Grégory VOISIN – CEO and founder ToxiPlan

Investors of the class of 2024

Our financiers